Literature DB >> 17935073

Pathogenic T cells in MOBP-induced murine EAE are predominantly focused to recognition of MOBP21F and MOBP27P epitopic residues.

Nathali Kaushansky1, Rina Zilkha-Falb, Reut Hemo, Hans Lassman, Miriam Eisenstein, Aldema Sas, Avraham Ben-Nun.   

Abstract

Myelin-associated oligodendrocytic basic protein (MOBP) is a central nervous system (CNS)-specific myelin constituent important in stabilizing the unique multi-layered structure of the CNS-myelin sheath. Although autoimmunity against MOBP has been associated with multiple sclerosis pathogenesis, anti-MOBP pathogenic T cells have been poorly investigated as compared to T cells against other encephalitogenic myelin proteins. We have recently determined MOBP15-36 as the major encephalitogenic epitope of MOBP for SJL/J mice. In this study, epitope-specificity was dissected to the level of residues crucial for activation/control of MOBP-specific encephalitogenic T cells. Structural bioinformatic analysis of MOBP15-36/I-A(s) interaction and experimental data have determined MOBP21F and MOBP27P of I-A(s)-binding nonameric core epitope (MOBP20-28) as TCR-contact residues critical for functional activation of encephalitogenic MOBP-specific T cells. Accordingly, the non-encephalitogenic/nonstimulatory pMOBP16-21A27A-33 inhibited encephalitogenic MOBP-reactive T cells, shifted their cytokine secretion profile, and effectively suppressed pMOBP15-36-induced EAE. Moreover, pMOBP16-21A27A-33 fully reversed ongoing clinical EAE induced by whole MOBP as well as by pMOBP15-36. Data show that encephalitogenic MOBP-reactive T cells are predominantly focused to recognition of MOBP21F and MOBP27P, and suggest that both their selection and control are governed by MOBP21F and MOBP27P epitopic residues. Such focused epitopic recognition may affect profoundly on peripheral self-tolerance to MOBP and on potential altered peptide ligand-mediated therapy of MOBP-related autoimmune pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17935073     DOI: 10.1002/eji.200737438

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  An immunomodulating motif of the HIV-1 fusion protein is chirality-independent: implications for its mode of action.

Authors:  Omri Faingold; Avraham Ashkenazi; Nathali Kaushansky; Avraham Ben-Nun; Yechiel Shai
Journal:  J Biol Chem       Date:  2013-09-27       Impact factor: 5.157

2.  DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).

Authors:  Nathali Kaushansky; Daniel M Altmann; Chella S David; Hans Lassmann; Avraham Ben-Nun
Journal:  J Neuroinflammation       Date:  2012-02-08       Impact factor: 8.322

Review 3.  Optical coherence tomography monitoring and diagnosing retinal changes in multiple sclerosis.

Authors:  Arshad Mehmood; Wajid Ali; Shuang Song; Zaheer Ud Din; Ruo-Yi Guo; Wahid Shah; Ikram Ilahi; Bowen Yin; Hongjing Yan; Lu Zhang; Murad Khan; Wajid Ali; Liaqat Zeb; Hamidreza Safari; Bin Li
Journal:  Brain Behav       Date:  2021-09-14       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.